Patent: 9,649,340
✉ Email this page to a colleague
Summary for Patent: 9,649,340
Title: | Methods for producing enriched populations of human retinal pigment epithelium cells |
Abstract: | This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells. |
Inventor(s): | Klimanskaya Irina V., Lanza Robert P. |
Assignee: | Astellas Institute for Regenerative Medicine |
Application Number: | US12857866 |
Patent Claims: | see list of patent claims |
Details for Patent 9,649,340
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | PLASMANATE | plasma protein fraction (human) | Injection | 101140 | October 02, 1958 | 9,649,340 | 2030-08-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |